Eslami: Rising demand drives Iran’s nuclear exports to dozens of countries
The Islamic Republic is currently exporting nuclear products, including radiopharmaceuticals, heavy water, and its derivatives, to dozens of countries, the head of the Atomic Energy Organization of Iran (AEOI) said, noting that about 56 nations have requested and continue to seek such items.
In an interview with the Iranian Labour News Agency (ILNA), AEOI chief Mohammad Eslami said, “About 56 countries have requested our products and continue to do so. For those not affected by transport sanctions, we are exporting. For those facing transport sanctions, we are seeking solutions to deliver products to end users.”
Eslami emphasized that Iran’s nuclear products enjoy strong and growing international demand. “Our product balance is global, and there is a worldwide market for them,” he said. “We also receive formal programs from interested countries that wish to become regular consumers of our products.”
The remarks follow Iran’s unveiling of four new strategic achievements in nuclear technology last week at the 26th International Research, Technology, and Innovation Exhibition, which included two radiopharmaceuticals for the early diagnosis and treatment of metastatic melanoma, an automated system for producing bone pain palliation drugs, and the launch of a national nuclear education network.
At the ceremony, Eslami highlighted the AEOI’s dual scientific and industrial role, noting that its innovations carry significant social and economic impact.
“We are a successful symbol of sustaining the cycle of creativity and innovation — where knowledge is transformed into technology, and technology into usable systems and solutions in the shortest possible time,” he said. “This transformation — from science to practical, people-centered solutions — has been realized within our organization.”
Recalling past milestones, Eslami noted that Iran announced 50 domestically produced radiopharmaceuticals in 2023, with 20 more in the research phase. “Today, I am proud to report that we have reached up to 70 radiopharmaceuticals,” he said.